华人健康 (301408)
Anhui Huaren Health Pharmaceutical Co.,Ltd.
K-Line Chart
No K-line data available
Company NameAnhui Chinese Health Pharmaceutical Co., Ltd.
Listing Date2023-03-01
Issue Price16.24RMB
Registered Capital4000110k RMB
Legal RepresentativeHe Jiale
Registered AddressNo. 123 Hebei Road, Baohe District, Hefei City, Anhui Province
IndustryPharmaceutical Commerce
Main BusinessPharmaceutical Agency, Retail, and Terminal Centralized Procurement
Company ProfileAnhui Chinese Health Pharmaceutical Co., Ltd., founded in 2001, is headquartered in Hefei, Anhui Province. The group company has consistently focused on the pharmaceutical and health industry, covering multiple fields such as pharmaceutical marketing, health & wellness, retail, commerce, and consulting management. After years of development, it has evolved into a large-scale pharmacy ecosystem group enterprise that operates scientifically with a five-in-one structure centered around pharmaceutical terminals. This structure comprises: Anhui Chinese Health Pharmaceutical Co., Ltd. as the product output platform; Anhui Guosheng Pharmacy Chain Co., Ltd. as the retail platform; Anhui Huida Pharmaceutical Co., Ltd. as the supply chain management platform; the Pharmacy Business School as the management output platform; and Hefei Jiezhu Pharmaceutical Technology Co., Ltd. as the information technology service platform.
Stock Details
1. Key Indicators
- Total Shares(W): 40001.00
- Circulating A-Shares(W): 14917.13
- Earnings Per Share(RMB): 0.3918
- Net Assets Per Share(RMB): 5.2399
- Operating Revenue(W RMB): 389246.41
- Total Profit(W RMB): 22235.07
- Net Profit Attributable to Parent(W RMB): 15672.66
- Net Profit Growth Rate(%): 45.21
- Weighted Return on Equity(%): 7.62
- Operating Cash Flow Per Share(RMB): 1.4750
- Undistributed Profit Per Share(RMB): 1.7540
- Capital Reserve Per Share(RMB): 2.3757
2. Main Business
The main business covers:
- Pharmaceutical Retail
- Pharmaceutical Agency
- Terminal Centralized Procurement Business
3. Company Basic Information
- Company Name: Anhui Huaren Health Pharmaceutical Co., Ltd.
- Listing Date: 2023-03-01
- Industry: Retail
- Address: Building A1, No. 123 Hebei Road, Hefei City, Anhui Province
- Website: www.hrjkjt.com
- Company Profile: The company was established through the overall change of Anhui Huaren into a joint stock limited company. On December 1, 2013, the shareholders' meeting of Anhui Huaren resolved to change into a joint stock limited company. On January 18, 2014, the founding meeting of the company approved the proposal to change Anhui Huaren into a joint stock company, based on the audited net assets of Anhui Huaren as of December 31, 2013, amounting to 27.534 million RMB, which were converted into 24 million shares of the company. On January 20, 2014, Huaren Health completed the industrial and commercial change registration with the Hefei Administration for Industry and Commerce.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Alibaba Health Information Technology (China) Co., Ltd. | General Legal Person | 1600.03 | 10.73 |
| 2 | Suzhou SAIF Puxin Medical Health Industry Investment Center (Limited Partnership) | General Legal Person | 1273.18 | 8.54 |
| 3 | Huatai Zijin Investment Co., Ltd. - Nanjing Huatai Great Health No.1 Equity Investment Partnership (Limited Partnership) | General Legal Person | 604.63 | 4.05 |
| 4 | Huangshan SAIF Tourism Cultural Industry Development Fund (Limited Partnership) | General Legal Person | 553.14 | 3.71 |
| 5 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 232.03 | 1.56 |
| 6 | Beijing Daotong Changjing Investment Management Center (Limited Partnership) | General Legal Person | 92.10 | 0.62 |
| 7 | Tianjin SAIF Shengyuan Investment Management Center (Limited Partnership) - Jiaxing Tengyuan Investment Partnership (Limited Partnership) | General Legal Person | 92.10 | 0.62 |
5. Concept Sectors
- New Retail
- Elderly Care Concept
- Alibaba Concept
- Artificial Intelligence
- Innovative Drugs
- Synthetic Biology
- AI Medical
- Margin Trading & Securities Lending
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information